Abstracts Archive - Page 107 of 1683 - ATC Abstracts

2022 American Transplant Congress
Type 1 Natural Killer T-cells: Key Mediators of Ischemia- Reperfusion Injury in Hepatic Steatosis
J. R. Liggett¹, J. Kang¹, K. Loh¹, K. Oza¹, Y. Cui¹, D. Kwon², H. Li³, B. Kallakury², T. Fishbein¹, W. Cui¹, K. Khalid¹, A. H. Kroemer¹
¹MedStar Georgetown Transplant Institute, Washington, DC, ²Pathology, MedStar Georgetown University Hospital, Washington, DC, ³Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
*Purpose: Hepatic ischemia-reperfusion injury (IRI) poses a significant risk in liver transplantation and hepatic resection and is further exacerbated by hepatic steatosis. Type 1 Natural…
2022 American Transplant Congress
Single Blind Randomized Controlled Trial Comparing BNT162b2 Vs JNJ-78436735 Vaccine As An Additional Dose After Two Doses Of BNT162b2 Vaccine In Solid Organ Transplant (SOT) Recipients
Y. Natori¹, E. Martin², A. Mattiazzi³, J. Bini Viotti¹, K. S. Ortecho⁴, S. Pallikkuth⁵, S. Anjan¹, J. Simkins¹, G. Guerra³
¹Department of Medicine, Division of Infectious Diseases, University of Miami, Miami, FL, ²Department of Medicine, Division of Hepatology, University of Miami, Miami, FL, ³Department of Medicine, Division of Nephrology, University of Miami, Miami, FL, ⁴Miami Transplant Institute, Jackson Health System, Miami, FL, ⁵University of Miami, Miami, FL
*Purpose: Even though a high efficacy and immunogenicity of COVID-19 vaccines have been reported in the general population, vaccine immunogenicity is suboptimal in SOT recipients…
2022 American Transplant Congress
Patient and Provider Perspectives on Telehealth Clinic Visits Precipitated by the Covid-19 Viral Pandemic
L. Adamski¹, C. Alvarez¹, M. Patterson², C. Shen³, G. Kaur³, F. K. Butt³
¹Penn State College of Medicine, Hershey, PA, ²University of South Carolina, Greenville, SC, ³Penn State Milton S Hershey Medical Center, Hershey, PA
*Purpose: The transplant community had to adjust to a new way of practicing medicine during the COVID-19 viral pandemic. Our transplant center quickly adapted to…
2022 American Transplant Congress
Increased Use of DCD Liver Grafts Does Not Adversely Affect Outcomes: A Single-Center Experience
M. Finotti, G. McKenna, H. Fernandez, J. Bayer, S. Lee, E. Martinez, N. Onaca, G. Saracino, R. Ruiz, G. Testa, A. Wall, A. Gupta
Baylor University Medical Center/Baylor Simmons Transplant Institute, Dallas, TX
*Purpose: Donation after circulatory death (DCD) donors are underutilized in liver transplantation (LT), partly due to fear of inferior outcomes. Our center has evolved from…
2022 American Transplant Congress
Time-Dependent Blood Eosinophilia Count Increases the Risk of Kidney Allograft Rejection
L. Colas¹, L. Bui², C. Kerleau³, M. Lemdani⁴, K. Autain-Renaudin⁵, A. Magnan⁶, M. Giral³, S. Brouard¹
¹CRT2I, Université de Nantes, Nantes, France, ²Service de Néphrologie, Centre Hospitalier de Mouscron, Mouscron, Belgium, ³Service de Néphrologie et Immunologie Clinique, CHU de Nantes, Nantes, France, ⁴Département de Biomathématiques, Université de Lilles, Lilles, France, ⁵Service d'Anatomie et Cytologie Pathologique, CHU de Nantes, Nantes, France, ⁶INRAe UMR 0892, Université de Versailles Saint-Quentin Paris-Saclay, Paris, France
*Purpose: There is growing evidence that type 2 immune effectors (immunoglobulin E, eosinophils, mast cells/basophils) play a role in autoimmune disorders and solid organ transplantation.…
2022 American Transplant Congress
Allo-Sensitization is Increased in Liver Transplant Recipients Following Ischemia-Reperfusion Injury
R. A. Sosa, A. Q. Terry, Y. Yin, B. V. Naini, F. M. Kaldas, R. W. Busuttil, D. W. Gjertson, J. W. Kupiec-Weglinski, E. F. Reed
UCLA, Los Angeles, CA
*Purpose: Recipient sensitization to donor HLA antigens remains an important clinical problem in transplantation, leading to increased wait times to find a compatible donor and…
2022 American Transplant Congress
Health Care Transition of Adolescents After Kidney Transplantation in Germany and Austria – The Randomized Controlled Transnephro Trial
L. Pape¹, M. Kreuzer¹, A. Großhenig², J. Prüfe¹, S. Group³
¹Pediatrics II, University Hospital of Essen, Essen, Germany, ²Biostatistics, Hannover Medical School, Hannover, Germany, ³German Society of Pediatric Nephrology, Berlin, Germany
*Purpose: Adolescence is the age with the highest rate of graft losses because of non-adherence and the transfer from pediatric to adult care. Health care…
2022 American Transplant Congress
Center Variation is the Major Driver of Geographic Disparities in Access to Kidney Transplants Among Waitlisted Candidates
D. Stewart, A. Robinson, A. Wilk, D. Klassen
United Network for Organ Sharing, Richmond, VA
*Purpose: The OPTN’s monitoring of equity in access to deceased donor kidney (KI) transplants (tx) among waitlisted candidates has consistently found service area (DSA) of…
2022 American Transplant Congress
Can We Predict Progression of Potential Donation After Cardiac Death Donors (DCD) Using DonorNet?
Y. Bababekov¹, A. Yule¹, H. Moore¹, R. Choudhury², C. Hertert³, T. Pshak⁴, T. Nydam⁵, B. Kaplan¹, E. Pomfret¹, J. Pomposelli⁵
¹Transplant Surgery, University of Colorado, Aurora, CO, ²University of Colorado Hospital, Denver, CO, ³Donor Alliance, Denver, CO, ⁴University of Colorado, Denver, CO, ⁵University of Colorado, Aurora, CO
*Purpose: DCD utilization of livers is limited by unpredictability of progression, perceived worse outcome, and costs related to deployment of resources. We aimed to predict…
2022 American Transplant Congress
The Impact of the New Allocation System of Kidney Transplantation on a Single Institution
M. Eltemamy, Y. Lin, M. Khalil, S. Agrawal, V. Krishnamurthi, A. Wee
The Cleveland Clinic, Cleveland, OH
*Purpose: The new kidney allocation system went into effect in the middle of March 2021. The consequences of this new system affected transplant centers differently,…